Skip to content


  • Poster presentation
  • Open Access

Elevated titers of anti-ribosomal-P antibodies in systemic lupus erythematosus

  • 1,
  • 1,
  • 1,
  • 1,
  • 2 and
  • 1
Arthritis Research & Therapy20057 (Suppl 1) :P13

  • Received: 11 January 2005
  • Published:


  • Public Health
  • Arthritis
  • Systemic Lupus Erythematosus
  • Serum Sampling
  • Renal Disease


Ribosomal P is located in the cytoplasm. The detection of antibodies is to the 60 kda fraction. Anti-ribosomal P antibodies are highly specific for systemic lupus erythematosus (SLE), and are detected at a 15–20% frequency according to the literature. Elevated anti-ribosomal P titers correlate with disease activity and are specifically associated with neuropsychiatric disease such as psychosis/depression. and coexist with anti-dsDNA antibodies. The aim of our study was to evaluate the frequency of anti-ribosomal P antibody titers and the correlation with manifestations in SLE patients.


Sera samples from 174 individuals were evaluated for titers of anti-ribosomal P antibodies: 77 samples from SLE patients, 22 patients with antiphospholipid syndrome (APS), 20 patients with familial Mediterranean fever, 12 patients with infections, and 43 healthy controls. Anti-ribosomal P antibody titers were tested by ELISA. Manifestations of SLE at the time of serum sampling were determined by the SLEDAI score.


Six SLE patients (11%) harbored elevated anti-ribosomal P antibody titers. Five SLE patients were females, mean age 44.3 years (range, 18–73 years old), and the mean SLEDAI mean score was 7 (range, 3–10) indicating moderate disease. Elevated titers of anti-dsDNA were detected in 50% of SLE patients with elevated anti-ribosomal P antibodies. One patient had secondary APS. One patient with elevated titers of anti-ribosomal had renal disease and psychosis. Three patients had a rash, while none of the patients had arthritis or leukopenia. Anti-ribosomal P titers were not elevated in patients with primary APS, familial Mediterranean fever, infections, or in healthy controls.


The prevalence of elevated titers of anti-ribosomal P antibodies was restricted to SLE patients. No correlation with a specific manifestation was found.

Authors’ Affiliations

Center for Autoimmune Diseases and Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel
Rheumatology Unit, Sackler Faculty of Medicine, Tel-Aviv University, Israel


© BioMed Central Ltd 2005